BEAM
Price
$24.53
Change
+$1.09 (+4.65%)
Updated
Jan 21 closing price
Capitalization
2.03B
41 days until earnings call
CRSP
Price
$41.51
Change
+$0.98 (+2.42%)
Updated
Jan 21 closing price
Capitalization
3.54B
27 days until earnings call
Ad is loading...

BEAM vs CRSP

Header iconBEAM vs CRSP Comparison
Open Charts BEAM vs CRSPBanner chart's image
Beam Therapeutics
Price$24.53
Change+$1.09 (+4.65%)
Volume$802.9K
Capitalization2.03B
CRISPR Therapeutics AG
Price$41.51
Change+$0.98 (+2.42%)
Volume$1.81M
Capitalization3.54B
BEAM vs CRSP Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. CRSP commentary
Jan 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and CRSP is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 22, 2025
Stock price -- (BEAM: $24.53 vs. CRSP: $41.51)
Brand notoriety: BEAM and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 69% vs. CRSP: 99%
Market capitalization -- BEAM: $2.03B vs. CRSP: $3.54B
BEAM [@Biotechnology] is valued at $2.03B. CRSP’s [@Biotechnology] market capitalization is $3.54B. The market cap for tickers in the [@Biotechnology] industry ranges from $341.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while CRSP’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 3 bearish.
  • CRSP’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +5.28% price change this week, while CRSP (@Biotechnology) price change was +8.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.46%. For the same industry, the average monthly price growth was +2.44%, and the average quarterly price growth was -0.23%.

Reported Earning Dates

BEAM is expected to report earnings on May 13, 2025.

CRSP is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (+2.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.54B) has a higher market cap than BEAM($2.03B). CRSP YTD gains are higher at: 5.462 vs. BEAM (-1.089). BEAM has higher annual earnings (EBITDA): -160.83M vs. CRSP (-313.08M). CRSP has more cash in the bank: 1.94B vs. BEAM (926M). BEAM has less debt than CRSP: BEAM (162M) vs CRSP (228M). BEAM has higher revenues than CRSP: BEAM (350M) vs CRSP (200M).
BEAMCRSPBEAM / CRSP
Capitalization2.03B3.54B57%
EBITDA-160.83M-313.08M51%
Gain YTD-1.0895.462-20%
P/E RatioN/AN/A-
Revenue350M200M175%
Total Cash926M1.94B48%
Total Debt162M228M71%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMCRSP
RSI
ODDS (%)
N/A
Bullish Trend 14 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 14 days ago
82%
Bullish Trend 14 days ago
77%
Momentum
ODDS (%)
Bearish Trend 14 days ago
89%
Bullish Trend 14 days ago
76%
MACD
ODDS (%)
Bearish Trend 14 days ago
86%
Bullish Trend 14 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 14 days ago
82%
Bullish Trend 14 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 14 days ago
83%
Bearish Trend 14 days ago
86%
Advances
ODDS (%)
Bullish Trend 15 days ago
81%
Bullish Trend 20 days ago
81%
Declines
ODDS (%)
Bearish Trend 20 days ago
85%
Bearish Trend 14 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 14 days ago
74%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 14 days ago
84%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRGRX56.870.56
+0.99%
MFS Core Equity I
MVALX39.11N/A
N/A
Meridian Contrarian Legacy
CHUCX25.07N/A
N/A
Alger Global Equity C
TEMPX7.86N/A
N/A
Nuveen Emerging Markets Eq Prem
AIBBX15.94N/A
N/A
Aristotle Small Cap Equity I-2